Ausgabe 4/2021
Inhalt (23 Artikel)
ASCO 2021: Highlights in central nervous system tumors
Maximilian J. Mair, Anna S. Berghoff
Best of ASCO 2021: new data from triple-negative breast cancer
Christian Singer
ASCO 2021 highlights head and neck cancer: nasopharyngeal carcinoma
Thorsten Fuereder
Ovarian cancer—ASCO annual meeting update 2021
Johannes Schöche, Kathrin Strasser-Weippl
ASCO 2021—selection of personal highlights in early stage non-small cell lung cancer
Gudrun Absenger, Andreas Pircher
Practical considerations for the management of immune thrombocytopenic purpura
Michael Fillitz, Barbara Dixer, Felix Keil
Value of autophagy-related gene 5 (ATG5) expression as a prognostic marker in adults with newly diagnosed acute lymphoblastic leukaemia (ALL)
Rasha I. Ibrahim, Haydi S. Mohamed, Mary G. Nagib, Hebatullah M. Fares, Alia M. Saeed
The double-edged sword of immune checkpoint inhibition in advanced staged thymic epithelial tumours
Wolfgang Jungraithmayr
Unresectable pleural mesothelioma—hope or still an unmet medical need?
Gudrun Absenger, Angelika Terbuch
Neuroendocrine neoplasms of the lung: a pathology update
Jasna Metovic, Marco Barella, Giuseppe Pelosi
Detection of acquired resistance mutation ALK G1202R after treatment with alectinib and response of lorlatinib
Louisa Hempel, Jakob Molnar, Andreas Gaumann, Sebastian Robert, Josef Scheiber, Axel Kleespies, Kristina Riedmann, Susanne Schreiber, Beate Gandorfer, Armin Piehler, Dirk Hempel
Rare lung cancers—Primary pulmonary leiomyosarcoma: A case report
Laurenz Nagl, Andreas Seeber, Gerlig Widmann, Katja Schmitz, Herbert Maier, Georg Pall, Dominik Wolf, Andreas Pircher
The value of immunotherapy in pediatric leukemia and lymphoma
Elisabeth Salzer, Andishe Attarbaschi
Ponatinib and palbociclib combination in TKI-resistant CML—A case report
Johannes B. Jaeger, Thomas Jaeger, Sandra Preuner, Petra Pusic, Isabella Sponseiler, Thomas Lion, Thomas Winder, Bernd Lorenz Hartmann